Name : Dr U K Mishra (65Y/M)
Date : 07 Dec 2024
Test Asked : Psa, Iron Deficiency Profile + 1 Others
Report Status: Complete Report
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004
NAME : DR U K MISHRA (65Y/M) SAMPLE COLLECTED AT :
REF. BY : SELF
(8230028136),GANGA SEVA SADAN,OPPOSITE
TEST ASKED : PSA,IRON DEFICIENCY PROFILE,FERR JAGJIVAN COLLAGE , BULLA SAHID GAYA ,
BIHAR,823003
Report Availability Summary
Note: Please refer to the table below for status of your tests.
3 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab
TEST DETAILS REPORT STATUS
IRON DEFICIENCY PROFILE Ready
FERRITIN Ready
PROSTATE SPECIFIC ANTIGEN (PSA) Ready
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004
NAME : DR U K MISHRA (65Y/M) SAMPLE COLLECTED AT :
REF. BY (8230028136),GANGA SEVA SADAN,OPPOSITE
: SELF
JAGJIVAN COLLAGE , BULLA SAHID GAYA ,
TEST ASKED : FERRITIN,IRON DEFICIENCY PROFILE,PSA BIHAR,823003
TEST NAME TECHNOLOGY VALUE UNITS
IRON PHOTOMETRY 68 µg/dL
Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 319 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay
% TRANSFERRIN SATURATION CALCULATED 21 %
Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values
FERRITIN E.C.L.I.A 221 ng/mL
Bio. Ref. Interval. :
30 - 400
Method : Fully Automated Electrochemiluminescence Sandwich Immunoassay
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 250.87 µg/dL
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.
Sample Collected on (SCT) : 07 Dec 2024 09:51
Sample Received on (SRT) : 07 Dec 2024 22:50
Report Released on (RRT) : 08 Dec 2024 04:45
Sample Type : SERUM
Labcode : 0712103809/A8108 Dr T Priyanka MD(Path)
Barcode : CY498711
Page : 1 of 3
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004
NAME : DR U K MISHRA (65Y/M) SAMPLE COLLECTED AT :
REF. BY : SELF (8230028136),GANGA SEVA SADAN,OPPOSITE
JAGJIVAN COLLAGE , BULLA SAHID GAYA ,
TEST ASKED : FERRITIN,IRON DEFICIENCY PROFILE,PSA
BIHAR,823003
TEST NAME TECHNOLOGY VALUE UNITS
PROSTATE SPECIFIC ANTIGEN (PSA) C.L.I.A 1.35 ng/mL
Bio. Ref. Interval. :-
Normal : < 4.00 ng/ml
Border line : 4.01 to 10.00 ng/ml
Clinical Significance:
Elevated levels of PSA are associated with prostate cancer, but may also be seen with prostatitis (Inflammation of the prostate)
and benign prostatic hyperplasia (BPH). PSA test done along with free PSA provides additional information. Studies have
suggested that the percentage of free PSA in total PSA is lower in patients with prostate cancer than those with benign prostate
hyperplasia.
Specification:
Precision: Intra assay (%CV): 4.38%, Inter assay (%CV): 4.67%; Sensitivity: 0.01 ng/ml
Kit validation references:
Wang MC, Valenzuala LA, Murphy GP, and Chu TM. Purification of a human prostate-specific antigen. Invest. Urol. 1979; 17: 159
Please correlate with clinical conditions.
Method:- TWO SITE SANDWICH IMMUNOASSAY
~~ End of report ~~
Sample Collected on (SCT) : 07 Dec 2024 09:51
Sample Received on (SRT) : 07 Dec 2024 22:50
Report Released on (RRT) : 08 Dec 2024 04:45
Sample Type : SERUM
Dr T Priyanka MD(Path)
Labcode : 0712103809/A8108
Barcode : CY498711 Page : 2 of 3
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@thyrocare.com
or call us on 022-3090 0000
+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)
Page : 3 of 3
